Published in Gene Therapy Weekly, April 4th, 2002
Dr. High is currently involved in clinical trials seeking to improve blood clotting in patients with hemophilia B by using a genetically engineered virus to deliver beneficial genes. High delivered a Science Innovation Lecture to the American Association for the Advancement of Science recently in Boston.
"While current clinical studies look promising," she said,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly